- Home
- SRTS vs RPTX Comparison
SRTS vs RPTX Comparison
Compare SRTS & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRTS
- RPTX
- Stock Information
- Founded
- SRTS 2010
- RPTX 2016
- Country
- SRTS United States
- RPTX Canada
- Employees
- SRTS N/A
- RPTX N/A
- Industry
- SRTS Medical/Dental Instruments
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- SRTS Health Care
- RPTX Health Care
- Exchange
- SRTS Nasdaq
- RPTX Nasdaq
- Market Cap
- SRTS 75.5M
- RPTX 64.8M
- IPO Year
- SRTS 2016
- RPTX 2020
- Fundamental
- Price
- SRTS $5.33
- RPTX $1.53
- Analyst Decision
- SRTS Strong Buy
- RPTX Strong Buy
- Analyst Count
- SRTS 3
- RPTX 3
- Target Price
- SRTS $11.67
- RPTX $4.50
- AVG Volume (30 Days)
- SRTS 134.3K
- RPTX 701.4K
- Earning Date
- SRTS 08-07-2025
- RPTX 08-12-2025
- Dividend Yield
- SRTS N/A
- RPTX N/A
- EPS Growth
- SRTS N/A
- RPTX N/A
- EPS
- SRTS 0.11
- RPTX N/A
- Revenue
- SRTS $39,488,000.00
- RPTX $1,073,000.00
- Revenue This Year
- SRTS $4.33
- RPTX N/A
- Revenue Next Year
- SRTS $26.74
- RPTX N/A
- P/E Ratio
- SRTS $47.72
- RPTX N/A
- Revenue Growth
- SRTS 24.75
- RPTX N/A
- 52 Week Low
- SRTS $4.01
- RPTX $0.89
- 52 Week High
- SRTS $9.33
- RPTX $4.07
- Technical
- Relative Strength Index (RSI)
- SRTS 57.88
- RPTX 53.63
- Support Level
- SRTS $5.21
- RPTX $1.48
- Resistance Level
- SRTS $5.92
- RPTX $1.56
- Average True Range (ATR)
- SRTS 0.39
- RPTX 0.05
- MACD
- SRTS 0.04
- RPTX -0.01
- Stochastic Oscillator
- SRTS 63.80
- RPTX 35.71
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.